NumerixS Investment Technologies’s Takeda Pharmaceutical TAK Stock Holding History

NumerixS Investment Technologies’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16,600	Closed	-$298K	–	750
2020 Q2	$298K	Buy	16,600 +16,400	+8,200%	+$294K	0.08%	284
2020 Q1	$3K	Sell	200 -25,300	-99%	-$459K	﹤0.01%	953
2019 Q4	$503K	Buy	+25,500	New	+$488K	0.1%	234
2019 Q3	–	Sell	-19,300	Closed	-$342K	–	1220
2019 Q2	$342K	Buy	19,300 +2,300	+14%	+$41.9K	0.1%	258
2019 Q1	$352K	Buy	+17,000	New	+$342K	0.05%	481

Other funds holding TAK

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NumerixS Investment Technologies's TAK Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Takeda Pharmaceutical (TAK) in Q3 2020, closing a stake of 16,600 shares — an estimated $298K sold.

NumerixS Investment Technologies first reported a position in TAK in Q1 2019 and held it in 5 quarters. The position peaked at $503K in Q4 2019. 310 funds tracked by Wall St. Rank hold TAK as of Q3 2020.

NumerixS Investment Technologies reported no remaining Takeda Pharmaceutical position as of Q3 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 16,600 Takeda Pharmaceutical shares in Q3 2020, an estimated $298K.
NumerixS Investment Technologies first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 5 quarters.
NumerixS Investment Technologies's Takeda Pharmaceutical position peaked at $503K in Q4 2019.
310 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.